| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22ac5673c4dd061a9958c9903702bbe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2613944636ab2fdf3f83ef2d4b304f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb2253d1197694d0854f45d86d9e4312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e6cd3a50cc59ee03d29689c00297f46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aaee24837f39abce6787d58421e5b770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01850f3073298828827c8d2dca90a663 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C59-142 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C59-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate |
2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f3b02663ea0262811ccd8b2c54c172e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d17372b7ffd820f7b9b8e43d6e9cee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe26bda68fd4bc3db8a391175371c8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53c1fe57670f4410695d2bf9fbce7dc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8703ed48ce3932d99a4ce584b4f3594 |
| publicationDate |
2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02070032-A1 |
| titleOfInvention |
Plasma surface graft process for reducing thrombogenicity |
| abstract |
In accordance with the present invention, there is provided a novel process for modifying the surface properties of a material that is suitable for contact with animal tissue so as to enhance its hemocompatibility and make it less thrombogenic when in use. This process comprises: Exposing the surface of the material to plasma treatment conditions in order to create reactive groups on said surface; activating a molecule with an activator to produce a reactive molecular species capable of forming convalent bonds with the reactive groups created on the surface of the material to form convalent bonds. The invention further encompasses the materials produced by this process as well as devices, such as vascular prosthesis, that are comprised of these process-modified materials. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007515974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7597924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022174-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022174-A2 |
| priorityDate |
2001-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |